[ Price : $8.95]
Federal Register Notice: FDAs Nonprescription Drugs Advisory Committee will meet 12/14 to discuss the safety and effectiveness of ...[ Price : $8.95]
CDER warns Sanofi-Aventis over failures to properly conduct a Ketek clinical trial.[ Price : $8.95]
FDA says Cephalon has updated Provigils (modafinil) labeled warnings to include information on serious rashes, including Stevens-J...[ Price : $8.95]
Dendreon completes enrollment in a Provenge Phase 3 study needed to provide additional efficacy data to FDA.[ Price : $8.95]
Consulting editor John Scharmann replies to a critic who alleged there were two false premises in a recent article about animal an...[ Price : $8.95]
FDA approves a Sun Pharmaceutical Industries ANDA for a generic version of Novartis's Exelon caspsules, indicted for treating Alzh...[ Price : $8.95]
FDA suggests a temporary enrollment suspension in Delcath System Phase 2 and 3 trials due to safety concerns.[ Price : $8.95]
FDAs Nonprescription Drugs Advisory Committee plans a 12/14 meeting to review re-formulated over-the-counter oral nasal decongesta...